ArticleParticle and fibre toxicology2026
Degradation reshapes the toxic identity of polylactic acid microplastics through MSR1-dependent immune decoding in mouse kidney.
Article in Particle and fibre toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Micro- and Nanoplastic Pollution and Renal Health: Human Evidence, Mechanisms, and Clinical Implications.Journal of xenobiotics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundBiodegradable plastics are increasingly being used as a sustainable alternative, but their degradation in biological environments may produce transformation products with unexpected toxicological characteristics. These products generate a distribution pattern in the kidneys that differs from other organs, with the accumulation of low-molecular-weight polylactic acid microplastics (PLA MPs) being far higher than that of high-molecular-weight tissues.
methodsPLA is used as a representative bioplastic. We used polymeric and oligomeric MPs to simulate their original and partially degraded states. Mice were exposed to these MPs through repeated oral administration under controlled experimental exposure conditions for 28 consecutive days to study the accumulation and inflammatory damage caused by PLA oligomer and polymer MPs in the kidneys. In combination with in vitro transcriptomic analysis, we explored the potential mechanisms by which oligomers drive nephrotoxicity.
resultsExposure to PLA oligomer MPs results in significantly higher accumulation in the kidneys compared to PLA polymer MPs, and triggers more severe inflammatory damage. The mechanism is that renal macrophages preferentially phagocytose PLA oligomer MPs and decode them through macrophage scavenger receptor 1 (MSR1), activating phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling and inducing chemokine ligand 2 (CCL2)-dependent macrophage recruitment, thereby establishing a self-amplifying inflammatory loop. Inhibiting MSR1 or PI3K/AKT effectively reduces oligomer-driven cytokine production, macrophage infiltration, and renal injury, narrowing the toxicity gap between oligomeric and polymeric PLA MPs in the kidneys.
conclusionsThese findings reveal that biodegradation can heighten the inflammatory potential of MPs, and that distinct polymerization states of the same material elicit different immune interpretations. Our work provides mechanistic clarity on how degradability reshapes microplastic toxicity, underscoring the need to incorporate degradation-state profiling into the safety assessment of biodegradable MPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.